Career Opportunities

At Genitope Corporation, our team of highly motivated and committed professionals is focused on the development and commercialization of novel therapies for cancer. Our lead product, MyVax® Personalized Immunotherapy (previously known as GTOP-99), is currently in a pivotal Phase 3 trial for the treatment of follicular non-Hodgkin's lymphoma.

We owe our ongoing success to both our talented team and our proprietary manufacturing process which allows us to efficiently produce patient-specific immunotherapies. Genitope can provide you with an opportunity to play a key role in the development of an innovative and personalized approach for treating cancer.